The AMEX Biotechnology Index rose for a fifth consecutivesession, closing up 3.81 Tuesday at 154.52. The index hasgained 23 points since last Tuesday.
Elan Corp. plc (AMEX:ELN) rose $1.88 to $48.13 after thecompany said it had net income of $21.3 million, or $1.05 pershare, on revenues of $100.7 million for the year ended March31.
The Athlone, Ireland, company, citing Standard & Poor's data,said its fourth consecutive year of at least 100 percent earningsgains made it the top earnings growth performer among U.S.-traded drug stocks.
Biochem Pharma Inc. (NASDAQ:BCHXF) continued its slide,losing $2.13 to $18.13. The stock has lost $9.12 since it closedat $27.25 on April 24.
(c) 1997 American Health Consultants. All rights reserved.